Search
Search Menu

Heads I win, tails you lose

Preclinical in vivo scientists often have to deal with a very interesting situation: Imagine we design a study to demonstrate that “our” drug can exert certain pharmacodynamic activity. As it unfortunately happens rather often, we design this study to include only one dose of our drug …

Read more

Scroll Up